Respiratory Tract Diseases

The research at Diamond Clinic focuses on Chronic Obstructive Pulmonary Disease (COPD) and moderate-to-severe asthma, evaluating new biologic agents aimed at reducing the frequency and severity of acute exacerbations.

  • Astegolimab efficacy in COPD
  • Rocatinlimab efficacy in asthma
  • Reduction of moderate and severe exacerbations
  • Placebo‑controlled safety assessments

Located in Cracow, Poland, the site collaborates with local investigators to advance therapeutic options for patients with chronic lung conditions.

Immune System Phenomena

Studies explore the role of the immune system in respiratory disease, testing antibodies that modulate immune pathways to improve disease control.

  • Targeted immunotherapy for airway inflammation
  • Biomarker analysis of immune response
  • Safety profiling of immune‑modulating agents

The clinic’s work contributes to a deeper understanding of immune‑driven mechanisms in lung disease, supporting future treatment development.